In this review
A broad catalogue still needs one useful purpose
Lavender Sky Health is worth comparing for someone who can name the care gap the purchase would fill. The service offers weight management, wellness treatments and laboratory services, with pharmacy-specific NAD+ and sermorelin options among its products. That breadth can help locate a service; it does not establish that several treatments belong in one person’s plan. [2] [8]
The $65 initial consultation buys evaluation and a written treatment plan. An established follow-up is $40. Medication is a separate financial decision, and clinical review may conclude that it is unsuitable. I would begin with the purpose of that evaluation rather than the size of the wellness menu. [1]
Compare the scope of care in our health-service comparisons.
For a recurring weight-care membership and eligible branded-drug coverage assistance, compare our Lemonaid Health review.
Payment control is different from a low complete cost
The practice says it does not take automatic recurring payments. Patients actively select consultations and treatment purchases. That is useful control, but a longer prepaid supply can still create a substantial commitment. A monthly equivalent describes comparison arithmetic, not necessarily an installment. [2] [3] [4]
Custom GLP-1 plans include their supplied medication and delivery-related inclusions. Standard branded-drug plans instead add a $25 monthly service-plan fee while the medication remains a separate pharmacy purchase. Those are different financial models. Neither should be presented as an all-inclusive longevity membership. [2] [3]
Keep the distinct purchases apart in the complete care-cost planner.
Formulation detail improves the buying discussion
The NAD+ table lists Strive’s 2,000 mg injection at $195, a range of other injections, nasal sprays and sublingual tablets. The sermorelin table separately lists injection quantities and oral blends, including a $199 Red Rock 15 mg injection. These are concrete details to use in a consultation, not established monthly supply prices. [2]
An injection, nasal spray, dissolving tablet and capsule have different exposure questions. A preparation does not acquire another route’s evidence through the ingredient name. Added vitamins or a second peptide also do not make a combination a more complete or more effective healthy-aging treatment.
Choose a meaningful outcome with the evidence on body composition and function.
Wellness language cannot substitute for outcomes
The NAD+ page presents cellular energy, focus and healthy-aging goals. The sermorelin page adds a natural-signaling comparison and recovery, sleep and body-composition claims. Those descriptions do not establish improved function, disease prevention or longer life from the selected commercial preparation. [5] [6]
FDA explains that compounded drugs are not approved and do not receive premarket safety, quality and effectiveness review. It also describes oversight and work with state authorities. The distinction is lack of approval, not a claim that the entire field is unregulated. A visible pharmacy name does not settle the product-specific outcome question. [7]
For a separate testing-platform decision, use our testing-service comparison.
The chosen pharmacy still needs to serve the patient
The FAQ permits selection among partners where they are available in the patient’s state. The practice describes service across all fifty states and DC while qualifying individual service, visit-format and pharmacy access. The menu therefore needs to be narrowed to the actual available prescription. [3] [4]
Care is delivered through remote consultation and portal communication. The ordinary follow-up framework and return-after-a-break rules need to be agreed for the actual plan. An available messaging channel is useful access, but it does not turn a focused treatment practice into comprehensive primary or preventive care. [1] [3]
A final-sale policy belongs in the value judgment
The policies generally make medication orders final after pharmacy submission and exclude credits for subsequent price changes. Delivered consultations and submitted electronic consultations also have restrictive refund terms. No automatic billing is therefore a feature of future purchasing control, not a broad money-back promise. [4]
Delivery and medication concerns must be reported to both the pharmacy and Lavender Sky within twenty-four hours. A separate prepayment balance has its own conditional refund rules; it should not be confused with an already purchased prescription. Buy the selected quantity only when the actual commitment is acceptable. [4]
Consider clinical continuity alongside the evidence after GLP-1 treatment stops.
Compare the relationship you would actually use
JumpstartMD is a useful alternative when a California clinic relationship and defined monitoring arrangements are attractive. Lavender Sky has a clearer fit when a reader wants remote, direct-pay care with pharmacy choices and is willing to manage each new purchase. Neither model establishes superior longevity outcomes.
Choose the additional care only when it adds something useful to an existing plan. If the main attraction is a larger catalogue, first decide which specific concern and outcome the purchase is supposed to address.
Compare the California clinic option in our JumpstartMD review.
Understanding the cost
Initial consultation $65; follow-up $40, plus the selected treatment. Examples: Strive NAD+ injection, 2,000 mg for $195; Red Rock sermorelin injection, 15 mg for $199. These are supplied quantities, not monthly treatment totals. Branded-drug plans add a $25 monthly service fee with medicine separate. There is no single inclusive healthy-aging membership. [1] [2]
Build your cost estimateSources
- Lavender Sky Health: consultation fees and expanded insurance/no-medication answers
- Lavender Sky Health: plan pricing with actual expanded NAD+ and sermorelin tables
- Lavender Sky Health: expanded pharmacy choice, plan inclusions and stopping FAQs
- Lavender Sky Health: practice availability, billing, refund, delivery and appointment policies
- Lavender Sky Health: NAD+ service and wellness claims
- Lavender Sky Health: sermorelin service and signaling claims
- FDA: compounded-drug risks, premarket review and risk-based oversight
- Lavender Sky Health: care model and treatment catalogue
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.